Analgesic, Anesthetic and Addiction Clinical Trials Innovations, Opportunities, and Networks (ACTTION)

The Analgesic, Anesthetic and Addiction Clinical Trials Innovations, Opportunities, and Networks (ACTTION) is a multi-year, multi-phase initiative aligned with the FDA's Critical Path Initiative. The goal of ACTTION is to streamline the discovery and development process for new analgesic, anesthetic, addiction, and peripheral neuropathy medications. Key objectives include initiating and supporting strategic collaborations among stakeholders, sharing data and innovative thinking, and developing innovative approaches in clinical trial designs. Some key points about this opportunity include: • The initiative is expected to develop innovative approaches in clinical trial designs to support regulatory decision making. • Strategic collaborations will involve a wide range of research projects and activities, such as scientific workshops and in-depth analyses of clinical trial data. • The initiative aims to share data and innovative thinking about the development of novel therapeutics. • Eligible applicants include independent school districts, for-profit organizations, city or township governments, and non-profits.